Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of severe hypercalcemia.

K D Davis1, M F Attie

  • 1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.

Critical Care Clinics
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofilament-light in former athletes: a potential biomarker of neurodegeneration and progression.

European journal of neurology·2020
Same author

Slow-5 dynamic functional connectivity reflects the capacity to sustain cognitive performance during pain.

NeuroImage·2017
Same author

Abnormal cortical activity in patients with temporomandibular disorder evoked by cognitive and emotional tasks.

Pain·2010
Same author

Stability of phantom limb phenomena after upper limb amputation: a longitudinal study.

Neuroscience·2008
Same author

Cortical thinning in IBS: implications for homeostatic, attention, and pain processing.

Neurology·2007
Same author

Intraoperative recording of the very fast oscillatory activities evoked by median nerve stimulation in the human thalamus.

Supplements to Clinical neurophysiology·2006

Severe hypercalcemia, often caused by tumors, requires urgent treatment. This case study highlights managing volume depletion and using bone resorption inhibitors like plicamycin for rapid calcium reduction.

Area of Science:

  • Nephrology
  • Endocrinology
  • Oncology

Background:

  • Severe hypercalcemia is a life-threatening condition, frequently linked to malignant tumors, advanced hyperparathyroidism, or vitamin D toxicity.
  • Malignancy-associated hypercalcemia presents with significant clinical challenges, including volume contraction, renal impairment, and neurological depression.

Observation:

  • The case study patient exhibited symptoms of dehydration and reduced renal function due to hypercalcemia.
  • Neurological symptoms, such as central nervous system depression, were noted, necessitating differential diagnosis including cerebral metastases.

Findings:

  • Intravenous fluid resuscitation is crucial for correcting volume depletion and promoting calcium excretion.
  • Bone resorption inhibitors (plicamycin, etidronate) and calcitonin are key in rapidly lowering serum calcium levels.

Related Experiment Videos

  • Treatment requires a multi-faceted approach, including supportive care and addressing the underlying cause, typically malignancy.

    • Implications:

    • Prompt and aggressive management of severe hypercalcemia is essential for preventing irreversible renal damage and improving patient outcomes.
    • Eradicating the underlying disease, particularly cancer, is paramount for long-term resolution of hypercalcemia.
    • Current treatments offer temporary control, emphasizing the need for definitive therapy against the primary pathology.